Summary of the epidemiological evidence relating snus to health

Regulatory Toxicology and Pharmacology

Volumn 59, Issue 2, 2011, Pages 197-214

  Lee, Peter N ^a  

^a PN Lee Statistics and Computing Ltd   (United Kingdom)

Author keywords

Cancer; Cessation; Circulatory disease; Oral disease; Smokeless; Tobacco

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE MEASUREMENT; CANCER RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; ESOPHAGUS CANCER; FEMALE; HEALTH HAZARD; HEART DISEASE; HUMAN; HYPERTENSION; LUNG CANCER; MALE; MENTAL DISEASE; MOUTH CANCER; MUSCULOSKELETAL DISEASE; OROPHARYNX CANCER; PANCREAS CANCER; PREGNANCY OUTCOME; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; RISK FACTOR; SMOKELESS TOBACCO; SMOKING CESSATION; SMOKING HABIT; STOMACH CANCER; SWEDEN; WEIGHT GAIN;

HEALTH; HUMANS; NEOPLASMS; SMOKING; SMOKING CESSATION; TOBACCO, SMOKELESS;

NICOTIANA TABACUM;

EID: 79952073373     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2010.12.002     Document Type: Article

References (163)

1. Agewall S., Persson B., Lindstedt G., Fagerberg B. Smoking and use of smokeless tobacco in treated hypertensive men at high coronary risk: utility of urinary cotinine determination. Br. J. Biomed. Sci. 2002, 59:145-149.
2. Ahlbom, A., Olsson, U.A., Pershagen, G., 1997. Health risks associated with Swedish snus, Symposium on snus arranged by the National Board of Health and Welfare, Stockholm, 19-20 September 1996. (Statistics of Sweden rapport 1997:11).
3. Ahmed E., Stegmayr B., Trifunovic J., Weinehall L., Hallmans G., Lefvert A.K. Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project. Stroke 2000, 31:1289-1293.
4. Andersson G., Axéll T. Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study. J. Oral Pathol. Med. 1989, 18:2-7.
5. Andersson G., Axéll T., Curvall M. Reduction in nicotine intake and oral mucosal changes among users of Swedish oral moist snuff after switching to a low-nicotine product. J. Oral Pathol. Med. 1995, 24:244-250.
6. Andersson G., Bjornberg G., Curvall M. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study. J. Oral Pathol. Med. 1994, 23:161-167.
7. Andersson G., Warfvinge G. The influence of pH and nicotine concentration in oral moist snuff on mucosal changes and salivary pH in Swedish snuff users. Swed. Dent. J. 2003, 27:67-75.
8. Ångman M., Eliasson M. Snus och blodtrych. Tvärsnittsstudie av viloblodtryck hos män i MONICA-studien i norra sverige. (Snuff and blood pressure. Cross-sectional study of blood pressure in rest among men in the MONICA study in Northern Sweden). Lakartidningen 2008, 105:3530-3535.
9. Asplund K., Nasic S., Janlert U., Stegmayr B. Smokeless tobacco as a possible risk factor for stroke in men - a nested case-control study. Stroke 2003, 34:1754-1759.
10. Attvall S., Fowelin J., Lager I., Von Schenck H., Smith U. Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. J. Intern. Med. 1993, 233:327-332.
11. Axéll T., Mörnstad H., Sundström B. The relation of the clinical picture to the histopathology of snuff dipper's lesions in a Swedish population. J. Oral Pathol. 1976, 5:229-236.
12. Axéll T.E. Oral mucosal changes related to smokeless tobacco usage: research findings in Scandinavia. Eur. J. Cancer B Oral Oncol. 1993, 29B:299-302.
13. Berggren U., Eriksson M., Fahlke C., Blennow K., Balldin J. Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects. Alcohol Alcohol. 2007, 42:267-271.
14. Bergström J., Keilani H., Lundholm C., Rådestad U. Smokeless tobacco (snuff) use and periodontal bone loss. J. Clin. Periodontol. 2006, 33:549-554.
15. Blomqvist G., Hirsch J.-M., Alberius P. Association between development of lower lip cancer and tobacco habits. J. Oral Maxillofac. Surg. 1991, 49:1044-1047.
16. Boffetta P., Aagnes B., Weiderpass E., Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int. J. Cancer 2005, 114:992-995.
17. Boffetta P., Hecht S., Gray N., Gupta P., Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008, 9:667-675.
18. Boffetta P., Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis (online first). BMJ 2009, 339:b3060.
19. Bolinder G., Alfredsson L., Englund A., de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am. J. Public Health 1994, 84:399-404.
20. Bolinder G., de Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am. J. Hypertens. 1998, 11:1153-1163.
21. Bolinder G., Norén A., de Faire U., Wahren J. Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men. Atherosclerosis 1997, 132:95-103.
22. Bolinder G., Norén A., Wahren J., de Faire U. Long-term use of smokeless tobacco and physical performance in middle-aged men. Eur. J. Clin. Invest. 1997, 27:427-433.
23. Bolinder G.M., Ahlborg B.O., Lindell J.H. Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. J. Intern. Med. 1992, 232:327-334.
24. Brattwall M., Warrén Stomberg M., Rawal N., Segerdahl M., Houltz E., Jakobsson J. Postoperative impact of regular tobacco use, smoking or snuffing, a prospective multi-center study. Acta Anaesthesiol. Scand. 2010, 54:321-327.
25. Broadstock, M., 2007. Systematic Review of the Health Effects of Modified Smokeless Tobacco Products (NZTA Report), vol. 10(1). New Zealand Health Technology Assessment, Christchurch. (accessed 10.10). http://www.nzhta.chmeds.ac.nz/publications/smokeless_tobacco.pdf.
26. Carlens C., Hergens M.-P., Grunewald J., Ekbom A., Eklund A., Höglund C.O., Askling J. Smoking, use of moist snuff and risk of chronic inflammatory diseases. Am. J. Respir. Crit. Care Med. 2010, 181:1217-1222.
27. Christensen, T., 2004. Euro-barometer 58.2: health and developing countries, October-December 2002 [computer file]. Inter-University Consortium for Political and Social Research, Ann Arbor, Michigan. (accessed 10.10). http://www.data-archive.ac.uk/findingData/snDescription.asp?sn=4810.
28. Colilla S.A. An epidemiologic review of smokeless tobacco health effects and harm reduction potential. Regul. Toxicol. Pharmacol. 2010, 56:197-211.
29. Conde-Agudelo A., Althabe F., Belizán J.M., Kafury-Goeta A.C. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am. J. Obstet. Gynecol. 1999, 181:1026-1035.
30. Critchley J.A., Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 2003, 58:435-443.
31. Danielson, M., 2003. Svenska skolbarns hälsovanor 2001/02. (Health behaviour in school-aged children. A WHO Collaborative Study). Statens Folkhälsoinstitut, (2003:50.) (accessed 10.10). http://www.fhi.se/shop/material_pdf/skolbarnshalsovanor0312.pdf.
32. Ekenvall L., Lindblad L.E. Vibrationsutlösta raynaudfenomen och nikotinkonsumtion - en preliminär rapport. (Vibration induced white fingers and nicotine - a preliminary report). Opusc. Med. 1985, 30:28-31.
33. Eliasson B., Taskinen M.-R., Smith U. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996, 94:878-881.
34. Eliasson M., Asplund K., Evrin P.-E., Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA study. Atherosclerosis 1995, 113:41-53.
35. Eliasson M., Asplund K., Nasic S., Rodu B. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J. Intern. Med. 2004, 256:101-110.
36. Eliasson M., Lundblad D., Hägg E. Cardiovascular risk factors in young snuff-users and cigarette smokers. J. Intern. Med. 1991, 230:17-22.
37. Ellingsen D.G., Thomassen Y., Rustad P., Molander P., Aaseth J. The time-trend and the relation between smoking and circulating selenium concentrations in Norway. J. Trace Elem. Med. Biol. 2009, 23:107-115.
38. England L.J., Levine R.J., Mills J.L., Klebanoff M.A., Yu K.F., Cnattingius S. Adverse pregnancy outcomes in snuff users. Am. J. Obstet. Gynecol. 2003, 189:939-943. Presented at the Annual Meeting of the Society for Maternal-Fetal Medicine, San Francisco, 7 February.
39. Fang F., Bellocco R., Hernan M.A., Ye W. Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis - a prospective cohort study. Neuroepidemiology 2006, 27:217-221.
40. Fernberg P., Odenbro A., Bellocco R., Boffetta P., Pawitan Y., Zendehdel K., Adami J. Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden. Cancer Res. 2007, 67:5983-5986.
41. Fernberg P., Odenbro A., Bellocco R., Boffetta P., Yudi Pawitan Y., Adami J. Tobacco use, body mass index and the risk of malignant lymphomas: a nationwide cohort study in Sweden. Int. J. Cancer 2006, 118:2298-2302.
42. Fleiss J.L., Gross A.J. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. J. Clin. Epidemiol. 1991, 44:127-139.
43. Forey, B., Hamling, J., Hamling, J., Lee, P. (Eds.), 2006-2009. International smoking statistics. A Collection of Historical Data from 30 Economically Developed Countries, web ed. P.N. Lee Statistics and Computing Ltd., Sutton, UK. http://www.pnlee.co.uk/iss.htm.
44. Forey, B.A., Hamling, J., Lee, P.N., 2010. International Mortality and Smoking Statistics IMASS Version 4.05. P.N. Lee Statistics and Computing Ltd., Sutton, Surrey. http://www.pnlee.co.uk/IMASS.htm.
45. Foulds J., Ramstrom L., Burke M., Fagerström K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob. Control 2003, 12:349-359.
46. Frithiof L., Anneroth G., Lasson U., Sederholm C. The snuff-induced lesion. A clinical and morphological study of a Swedish material. Acta Odontol. Scand. 1983, 41:53-64.
47. Furberg H., Bulik C.M., Lerman C., Lichtenstein P., Pedersen N.L., Sullivan P.F. Is Swedish snus associated with smoking initiation or smoking cessation?. Tob. Control 2005, 14:422-424.
48. Furberg H., Lichtenstein P., Pedersen N.L., Bulik C.M., Lerman C., Sullivan P.F. Snus use and other correlates of smoking cessation in the Swedish twin registry. Psychol. Med. 2008, 38:1299-1308.
49. Furberg H., Lichtenstein P., Pedersen N.L., Thornton L., Bulik C.M., Lerman C., Sullivan P.F. The STAGE cohort: a prospective study of tobacco use among Swedish twins. Nicotine Tob. Res. 2008, 10:1727-1735.
50. Galanti M.R., Rosendahl I., Post A., Gilljam H. Early gender differences in adolescent tobacco use - the experience of a Swedish cohort. Scand. J. Public Health 2001, 29:314-317.
51. Galanti M.R., Rosendahl I., Wickholm S. The development of tobacco use in adolescence among "snus starters" and "cigarette starters": an analysis of the Swedish "BROMS" cohort. Nicotine Tob. Res. 2008, 10:315-323.
52. Galanti M.R., Wickholm S., Gilljam H. Between harm and dangers. Oral snuff use, cigarette smoking and problem behaviours in a survey of Swedish male adolescents. Eur. J. Public Health 2001, 11:340-345.
53. Statistics with confidence. Confidence Intervals and Statistical Guidelines 1989, British Medical Journal, London. M.J. Gardner, D.G. Altman (Eds.).
54. Gilljam H., Galanti M.R. Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction 2003, 98:1183-1189.
55. Grotvedt L., Stigum H., Hovengen R., Graff-Iversen S. Social differences in smoking and snuff use among Norwegian adolescents: a population based survey. BMC Public Health 2008, 8:322-333.
56. Haglund B., Eliasson M., Stenbeck M., Rosén M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand. J. Public Health 2007, 35:618-622.
57. Halling A., Halling A., Unell L. General health and tobacco habits among middle-aged Swedes. Eur. J. Public Health 2007, 17:151-154.
58. Hankey G.J. Smoking and risk of stroke. J. Cardiovasc. Risk 1999, 6:207-211.
59. Hansson J., Pedersen N.L., Galanti M.R., Andersson T., Ahlbom A., Hallqvist J., Magnusson C. Use of snus and risk for cardiovascular disease: results from the Swedish twin registry. J. Intern. Med. 2009, 265:717-724.
60. Hansson L.-E., Baron J., Nyrén O., Bergström R., Wolk A., Adami H.-O. Tobacco, alcohol and the risk of gastric cancer. A population-based case-control study in Sweden. Int. J. Cancer 1994, 57:26-31.
61. Haukkala A., Vartiainen E., de Vries H. Progression of oral snuff use among Finnish 13-16-year-old students and its relation to smoking behaviour. Addiction 2006, 101:581-589.
62. Hedman L., Bjerg-Bäcklund A., Perzanowski M., Sundberg S., Rönmark E. Factors related to tobacco use among teenagers. Respir. Med. 2007, 101:496-502.
63. Hedström A.K., Bäärnhielm M., Olsson T., Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009, 73:696-701.
64. Heir T., Eide G. Injury proneness in infantry conscripts undergoing a physical training programme: smokeless tobacco use, higher age, and low levels of physical fitness are risk factors. Scand. J. Med. Sci. Sports 1997, 7:304-311.
65. Helgason A.R., Tomson T., Lund K.E., Galanti R., Ahnve S., Gilljam H. Factors related to abstinence in a telephone helpline for smoking cessation. Eur. J. Public Health 2004, 14:306-310.
66. Hergens M.-P., Ahlbom A., Andersson T., Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology 2005, 16:12-16.
67. Hergens M.-P., Alfredsson L., Bolinder G., Lambe M., Pershagen G., Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J. Intern. Med. 2007, 262:351-359.
68. Hergens M.-P., Lambe M., Pershagen G., Terent A., Ye W. Smokeless tobacco and the risk of stroke. Epidemiology 2008, 19:794-799.
69. Hergens M.-P., Lambe M., Pershagen G., Ye W. Risk of hypertension amongst Swedish male snuff users: a prospective study. J. Intern. Med. 2008, 264:187-194.
70. Hirsch J.-M., Hedner J., Wernstedt L., Lundberg J., Hedner T. Hemodynamic effects of the use of snuff. Clin. Pharmacol. Ther. 1992, 52:394-401.
71. Hirsch J.-M., Heyden G., Thilander H. A clinical, histomorphological and histochemical study on snuff-induced lesions of varying severity. J. Oral Pathol. 1982, 11:387-398.
72. Hirsch J.M., Livian G., Edward S., Noren J.G. Tobacco habits among teenagers in the city of Göteborg, Sweden, and possible association with dental caries. Swed. Dent. J. 1991, 15:117-123.
73. Holm H., Jarvis M.J., Russell M.A.H., Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology 1992, 108:507-511.
74. Holmberg S.A., Thelin A.G. Primary care consultation, hospital admission, sick leave and disability pension owing to neck and low back pain: a 12-year prospective cohort study in a rural population. BMC Musculoskelet. Disord. 2006, 7:66-73.
75. Huhtasaari F., Asplund K., Lundberg V., Stegmayr B., Wester P.O. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes?. BMJ 1992, 305:1252-1256.
76. Huhtasaari F., Lundberg V., Eliasson M., Janlert U., Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J. Am. Coll. Cardiol. 1999, 34:1784-1790.
77. Hvitfeldt, T., Nyström, S., 2009. Skolelevers drogvanor 2008. Centralförbundet för alkohol-och narkotikaupplysning, Stockholm. (CAN Report no. 114.) (accessed 10.10). http://www.can.se/documents/CAN/Rapporter/rapportserie/can-rapportserie-114-skolelevers-drogvanor-2008.pdf.
78. Idris A.M., Nair J., Oshima H., Friesen M., Brouet I., Faustman E.M., Bartsch H. Unusually high levels of carcinogenic nitrosamines in Sudan oral snuff (toombak). Carcinogenesis 1991, 12:1115-1118.
79. International Agency for Research on Cancer, 2007a. Smokeless tobacco and some tobacco-specific N-nitrosamines, vol. 89. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC, Lyon, France. , (accessed 10.10). http://monographs.iarc.fr/ENG/Monographs/vol89/mono89.pdf.
80. International Agency for Research on Cancer Tobacco habits other than smoking; betel-quid and areca-nut chewing; and some related nitrosamines, vol. 37. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 1985, IARC, Lyon, France.
81. International Agency for Research on Cancer IARC Handbooks of Cancer Prevention, Tobacco Control, vol 11: Reversal of Risk after Quitting Smoking 2007, IARC, Lyon, France.
82. Jakobsson U. Tobacco use in relation to chronic pain: results from a Swedish population survey. Pain Med. 2008, 9:1091-1097.
83. Janzon E., Hedblad B. Swedish snuff and incidence of cardiovascular disease. A population-based cohort study. BMC Cardiovasc. Disord. 2009, 9:21-27.
84. Johansson S.-E., Sundquist K., Qvist J., Sundquist J. Smokeless tobacco and coronary heart disease a 12-year follow-up study. Eur. J. Cardiovasc. Prev. Rehabil. 2005, 12:387-392.
85. Jungell P., Malmström M. Snuff-induced lesions in Finnish recruits. Scand. J. Dent. Res. 1985, 93:442-447.
86. Kallischnigg G., Weitkunat R., Lee P.N. Systematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States. BMC Oral Health 2008, 8:13.
87. Katsika D., Tuvblad C., Einarsson C., Lichtenstein P., Marschall H.U. Body mass index, alcohol, tobacco and symptomatic gallstone disease: a Swedish twin study. J. Intern. Med. 2007, 262:581-587.
88. Koskinen L.O., Blomstedt P.C. Smoking and non-smoking tobacco as risk factors in subarachnoid haemorrhage. Acta Neurol. Scand. 2006, 114:33-37.
89. Lagergren J., Bergström R., Lindgren A., Nyrén O. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int. J. Cancer 2000, 85:340-346.
90. Larsson Å., Axéll T., Andersson G. Reversibility of snuff dippers' lesion in Swedish moist snuff users: a clinical and histologic follow-up study. J. Oral Pathol. Med. 1991, 20:258-264.
91. Lee P.N. Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int. J. Epidemiol. 2007, 36:789-804.
92. Lee P.N., Hamling J.S. Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med. 2009, 7:36.
93. Lee P.N., Hamling J.S. The relation between smokeless tobacco and cancer in Northern Europe and North America. A commentary on differences between the conclusions reached by two recent reviews. BMC Cancer 2009, 9:256.
94. Levander S., Eberhard J., Lindström E. Nicotine use and its correlates in patients with psychosis. Acta Psychiatr. Scand. Suppl. 2007, 116(Suppl 435):27-32.
95. Lewin F., Norell S.E., Johansson H., Gustavsson P., Wennerberg J., Biörklund A., Rutqvist L.E. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998, 82:1367-1375.
96. Lindquist R., Nilsson B., Eklund G., Gahrton G. Increased risk of developing acute leukemia after employment as a painter. Cancer 1987, 60:1378-1384.
97. Lindström M., Isacsson S.-O. Smoking cessation among daily smokers, aged 45-69years: a longitudinal study in Malmö, Sweden. Addiction 2002, 97:205-215.
98. Lund K.E., Tefre E.M., Amundsen A., Nordlund S. Royking, bruk av snus og annen risikoatferd blant studenter (cigarette smoking, use of snuff and other risk behaviour among students). Tidsskr. Nor Laegeforen. 2008, 128:1808-1811.
99. Lundqvist G., Sandström H., Öhman A., Weinehall L. Patterns of tobacco use: a 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population. Scand. J. Public Health 2009, 37:161-167.
100. Luo J., Ye W., Zendehdel K., Adami J., Adami H.-O., Boffetta P., Nyrén O. Oral use of Swedish moist snuff (snus) and risk of cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007, 369:2015-2020.
101. Mahid S.S., Minor K.S., Soto R.E., Hornung C.A., Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin. Proc. 2006, 81:1462-1471.
102. Mattila V.M., Sahi T., Jormanainen V., Pihlajamäki H. Low back pain and its risk indicators: a survey of 7040 Finnish male conscripts. Eur. Spine J. 2008, 17:64-69.
103. Modéer T., Lavstedt S., Åhlund C. Relation between tobacco consumption and oral health in Swedish schoolchildren. Acta Odontol. Scand. 1980, 38:223-227.
104. Montén U., Wennström J.L., Ramberg P. Periodontal conditions in male adolescents using smokeless tobacco (moist snuff). J. Clin. Periodontol. 2006, 33:863-868.
105. Nafziger A.N., Lindvall K., Norberg M., Stenlund H., Wall S., Jenkins P.L., Pearson T.A., Weinehall L. Who is maintaining weight in a middle-aged population in Sweden? A longitudinal analysis over 10 years. BMC Public Health 2007, 12:108-117.
106. Nilsson M., Weinehall L., Bergström E., Stenlund H., Janlert U. Adolescent's perceptions and expectations of parental action on children's smoking and snus use; national cross sectional data from three decades. BMC Public Health 2009, 9:74.
107. Nilsson R. A qualitative and quantitative risk assessment of snuff dipping. Regul. Toxicol. Pharmacol. 1998, 28:1-16.
108. Nilsson R. De minimus non curat lex - virtual thresholds for cancer initiation by tobacco specific nitrosamines - prospects for harm reduction by smokeless tobacco. Int. J. Occup. Environ. Health 2006, 19:6-35.
109. Norberg M., Stenlund H., Lindahl B., Boman K., Weinehall L. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep's clothing?. Scand. J. Public Health 2006, 34:576-583.
110. Nordgren P., Ramström L. Moist snuff in Sweden - tradition and evolution. Br. J. Addict. 1990, 85:1107-1112.
111. Novo M., Hammarström A., Janlert U. Smoking habits - a question of trend or unemployment? A comparison of young men and women between boom and recession. Public Health 2000, 114:460-463.
112. Odenbro Å., Bellocco R., Boffetta P., Lindelöf B., Adami J. Tobacco smoking, snuff dipping and the risk of cutaneous squamous cell carcinoma: a nationwide cohort study in Sweden. Br. J. Cancer 2005, 92:1326-1328.
113. Osterdahl B.-G., Slorach S.A. N-Nitrosamines in oral snuff and chewing tobacco on the Swedish market in 1983. Food Addit. Contam. 1984, 1:299-305.
114. Osterdahl B.G., Jansson C., Paccou A. Decreased levels of tobacco-specific N-nitrosamines in moist oral snuff on the Swedish market. J. Agric. Food Chem. 2004, 52:5085-5088.
115. Persson, J., Sjöberg, I., Johansson, S.-E., 2004. Bruk och missbruk, vanor och ovanor. Hälsorelaterade levnadsvanor 1980-2002 (Health related habits of life 1980-2002). Levnadsförhållanden (Living Conditions), Statistiska Centralbyrån, (105.) (accessed 10.10) with additional data supplied by E. Högstorp, Statistiska Centralbyrån, 2005. http://www.scb.se/statistik/le/le0101/1980i02/le0101_1980i02_br_le105sa0401.pdf.
116. Persson P.-G., Hellers G., Ahlbom A. Use of oral moist snuff in inflammatory bowel disease. Int. J. Epidemiol. 1993, 22:1101-1103.
117. Persson P.G., Carlsson S., Svanström L., Östenson C.G., Efendic S., Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. J. Intern. Med. 2000, 248:103-110.
118. Pindborg J.J., Renstrup G. Studies in oral leukoplakias. II. Effect of snuff on oral epithelium. Acta Derm. Venereol. 1963, 43:271-276.
119. Ramström, L.M., 1986. Tobaksvanor i Sverige 1985. Resultat från NTS-Undersökningen 1985. (Tobacco Habits in Sweden 1985. Results from an NTS Study 1985). NTS, Stockholm. (Tema Tobak Nr. 3.).
120. Ramström L.M., Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob. Control 2006, 15:210-214.
121. Ramström, L.M., Tibblin, H., 1987. Tobaksvanor i Sverige 1986. Resultat från NTS-undersökningen 1986. (Smoking Habits in Sweden 1986. Results from a National Council on Smoking and Health [NTS] Study 1986). (Tema Tobak No 5.).
122. Ramström, L.M., Tibblin, H., 1988. Tobaksvanor i Sverige 1987. Resultat från NTS-undersökning 1987. (Tobacco habits in Sweden 1987. Results from study of National Association against Tobacco Damage 1987). NTS, Stockholm. (Tema Tobak Nr. 7.).
123. Richthoff J., Elzanaty S., Rylander L., Hagmar L., Giwercman A. Association between tobacco exposure and reproductive parameters in adolescent males. Int. J. Androl. 2008, 31:31-39.
124. Rintakoski K., Ahlberg J., Hublin C., Lobbezoo F., Rose R.J., Murtomaa H., Kaprio J. Tobacco use and reported bruxism in young adults: a nationwide Finnish twin cohort study. Nicotine Tob. Res. 2010, 12:679-683.
125. Rodu B., Stegmayr B., Nasic S., Asplund K. Impact of smokeless tobacco use on smoking in northern Sweden. J. Intern. Med. 2002, 252:398-404.
126. Rodu B., Stegmayr B., Nasic S., Cole P., Asplund K. Evolving patterns of tobacco use in northern Sweden. J. Intern. Med. 2003, 253:660-665.
127. Roed-Petersen B., Pindborg J.J. A study of Danish snuff-induced oral leukoplakias. J. Oral Pathol. 1973, 2:301-313.
128. Rogers J.M. Tobacco and pregnancy: overview of exposures and effects. Birth Def. Res. C. Embryo Today 2008, 84:1-15.
129. Rohani M., Agewall S. Oral snuff impairs endothelial function in healthy snuff users. J. Intern. Med. 2004, 255:379-383.
130. Rolandsson M., Hellqvist L., Lindqvist L., Hugoson A. Effects of snuff on the oral health status of adolescent males: a comparative study. Oral Health Prev. Dent. 2005, 3:77-85.
131. Roosaar A., Johansson A.L., Sandborgh-Englund G., Axéll T., Nyrén O. Cancer and mortality among users and nonusers of snus. Int. J. Cancer 2008, 123:168-173.
132. Roosaar A., Johansson A.L.V., Sandborgh-Englund G., Nyrén O., Axéll T. A long-term follow-up study on the natural course of snus-induced lesions among Swedish snus users. Int. J. Cancer 2006, 119:392-397.
133. Rosendahl K.I., Galanti M.R., Gilljam H., Ahlbom A. Knowledge about tobacco and subsequent use of cigarettes and smokeless tobacco among Swedish adolescents. J. Adolesc. Health 2005, 37:224-228.
134. Rosenquist K. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed. Dent. J. Suppl. 2005, 1-66.
135. Rosenquist K., Wennerberg J., Schildt E.-B., Bladström A., Hansson B.G., Andersson G. Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol. 2005, 125:991-998.
136. Salonen L., Axéll T., Helldén L. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J. Oral Pathol. Med. 1990, 19:170-176.
137. Schildt E.-B., Eriksson M., Hardell L., Magnuson A. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int. J. Cancer 1998, 77:341-346.
138. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), 2008. Health effects of smokeless tobacco products. European Commission, Health and Consumer Protection Directorate-General, Brussels. (accessed 10.10). http://www.ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf.
139. Severson H.H., Forrester K.K., Biglan A. Use of smokeless tobacco is a risk factor for cigarette smoking. Nicotine Tob. Res. 2007, 9:1331-1337.
140. Sponsiello-Wang Z., Weitkunat R., Lee P.N. Systematic review of the relation between smokeless tobacco and cancer of the pancreas in Europe and North America. BMC Cancer 2008, 8:356-368.
141. Stegmayr B., Eliasson M., Rodu B. The decline of smoking in northern Sweden. Scand. J. Public Health 2005, 33:321-324.
142. Stegmayr B., Johansson I., Huhtasaari F., Moser U., Asplund K. Use of smokeless tobacco and cigarettes - effects on plasma levels of antioxidant vitamins. Int. J. Vitam. Nutr. Res. 1993, 63:195-200.
143. Stenbeck M., Hagquist C., Rosén M. The association of snus and smoking behaviour: a cohort analysis of Swedish males in the 1990s. Addiction 2009, 104:1579-1585.
144. Stepanov I., Hecht S.S., Ramakrishnan S., Gupta P.C. Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. Int. J. Cancer 2005, 116:16-19.
145. Sundbeck M., Grahn M., Lönngren V., Månsson N.O., Råstam L., Lindblad U. Snuff use associated with abdominal obesity in former smokers. Scand. J. Public Health 2009, 37:487-493.
146. Teo K.K., Ounpuu S., Hawken S., Pandey M.R., Valentin V., Hunt D., Diaz R., Rashed W., Freeman R., Jiang L., Zhang X., Yusuf S. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006, 368:647-658.
147. Tillgren P., Haglund B.J., Lundberg M., Romelsjö A. The sociodemographic pattern of tobacco cessation in the 1980s: results from a panel study of living condition surveys in Sweden. J. Epidemiol. Community Health 1996, 50:625-630.
148. Timberlake D.S., Huh J., Lakon C.M. Use of propensity score matching in evaluating smokeless tobacco as a gateway to smoking. Nicotine Tob. Res. 2009, 11:455-462.
149. W-Dahl A., Toksvig-Larsen S. No delayed bone healing in Swedish male oral snuffers operated on by the hemicallotasis technique. A cohort study of 175 patients. Acta Orthopaedica 2007, 28:791-794.
150. Wadman, C., 2009. Levnadsvanor - Tobaksvanor. Statens Folkhälsoinstitut, (accessed 10.10). http://www.fhi.se/sv/Statistik-uppfoljning/Nationella-folkhalsoenkaten/Levnadsvanor/Tobaksvanor/.
151. Wallenfeldt K., Hulthe J., Bokemark L., Wikstrand J., Fagerberg B. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J. Intern. Med. 2001, 250:492-501.
152. Wändell P.E., Bolinder G., de Faire U., Hellénius M.-L. Association between metabolic effects and tobacco use in 60-year-old Swedish men. Eur. J. Epidemiol. 2008, 23:431-434.
153. Cancer incidence in five continents, vol. III 1976, International Agency for Research on Cancer, Lyon, France. J. Waterhouse, C. Muir, P. Correa, J. Powell (Eds.).
154. Weitkunat R., Sanders E., Lee P.N. Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health 2007, 7:334.
155. Wennberg P., Eliasson M., Hallmans G., Johansson L., Boman K., Jansson J.-H. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J. Intern. Med. 2007, 262:360-367.
156. 2 and prostacyclin metabolites in young men. Circulation 1991, 83:1698-1704.
157. Wickholm S., Söder P.-Ö., Galanti M.R., Söder B., Klinge B. Periodontal disease in a group of Swedish adult snuff and cigarette users. Acta Odontol. Scand. 2004, 62:333-338.
158. Wiium N., Aarø L.E., Hetland J. Subjective attractiveness and perceived trendiness in smoking and snus use: a study among young Norwegians. Health Educ. Res. 2009, 24:162-172.
159. Wikström A.-K., Cnattingius S., Galanti M.R., Kieler H., Stephansson O. Effect of Swedish snuff (snus) on preterm birth. BJOG 2010, 117:1005-1010.
160. Wikström A.K., Stephansson O., Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension 2010, 55:1254-1259.
161. Wolk K., Mallbris L., Larsson P., Rosenblad A., Vingård E., Ståhle M. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm. Venereol. 2009, 89:492-497.
162. Ye W., Ekström A.M., Hansson L.-E., Bergström R., Nyrén O. Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int. J. Cancer 1999, 83:223-229.
163. Zendehdel K., Nyrén O., Luo J., Dickman P.W., Boffetta P., Englund A., Ye W. Risk of gastroesophageal cancer among smokers and users of Scandinavian moist snuff. Int. J. Cancer 2008, 122:1095-1099.